NUTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nutex Health Inc (NUTX) is not a strong buy at the moment for a beginner investor with a long-term focus. The company's financial performance has significantly deteriorated, and there are no strong technical or proprietary trading signals to suggest immediate upside potential. While the stock may see minor short-term fluctuations, the lack of positive catalysts and weak financials make it unsuitable for long-term investment at this time.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 61.392, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 106.688 with resistance at 111.884 and support at 101.493. Overall, the technical indicators suggest a neutral to slightly bullish trend but lack strong conviction.
The company is hosting an earnings call on May 1, 2026, which could provide updates on its business strategy and financial performance.
Press release highlights risks such as economic changes and management dependence. No strong trading trends from hedge funds or insiders.
In Q4 2025, revenue dropped by -41.12% YoY to $151.68M, net income declined by -80.79% YoY to $11.83M, EPS fell by -82.47% YoY to 1.56, and gross margin decreased by -44.67% YoY to 30.42%. These figures indicate significant financial deterioration.
No recent analyst ratings or price target changes are available for NUTX.
